D. E. Shaw & Co., Inc. Glaukos Corp Call Options Transaction History
D. E. Shaw & Co., Inc.
- $114 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GKOS
# of Institutions
274Shares Held
43.6MCall Options Held
89.8KPut Options Held
236K-
Black Rock Inc. New York, NY7.9MShares$962 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.31MShares$646 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.13MShares$260 Million3.61% of portfolio
-
State Street Corp Boston, MA1.83MShares$222 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X01.61MShares$196 Million0.09% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $5.8B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...